List of Zetia drug patents

Zetia is owned by Organon.

Zetia contains Ezetimibe.

Zetia has a total of 4 drug patents out of which 2 drug patents have expired.

Expired drug patents of Zetia are:

  • US7030106
  • US7030106*PED

Zetia was authorised for market use on 25 October, 2002.

Zetia is available in tablet;oral dosage forms.

Zetia can be used as to reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate; reduction of elevated plasma sterol and/or stanol levels in a mammal.

The generics of Zetia are possible to be released after 30 April, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7030106 ORGANON Sterol absorption inhibitor compositions
Jan, 2022

(1 year, 3 days ago)

US7030106

(Pediatric)

ORGANON Sterol absorption inhibitor compositions
Jul, 2022

(6 months ago)

US7612058 ORGANON Methods for inhibiting sterol absorption
Oct, 2025

(2 years from now)

US7612058

(Pediatric)

ORGANON Methods for inhibiting sterol absorption
Apr, 2026

(3 years from now)

Drugs and Companies using EZETIMIBE ingredient

Market Authorisation Date: 25 October, 2002

Treatment: To reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate; Reduction of elevated plasma sterol and/or stanol levels in a mammal

Dosage: TABLET;ORAL

How can I launch a generic of ZETIA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in